CA

Carter R. Anderson

TU Teikoku Pharma Usa: 12 patents #3 of 32Top 10%
DL Diametrics Medical Limited: 6 patents #1 of 22Top 5%
BM Birch Point Medical: 5 patents #2 of 5Top 40%
VT Verde Environmental Technologies: 4 patents #1 of 3Top 35%
NU Nupathe: 2 patents #5 of 14Top 40%
TI Teva Pharmaceutical Industries: 2 patents #16 of 140Top 15%
IT International Technidyne: 1 patents #24 of 39Top 65%
📍 Inver Grove Heights, MN: #8 of 287 inventorsTop 3%
🗺 Minnesota: #1,443 of 52,454 inventorsTop 3%
Overall (All Time): #89,824 of 4,157,543Top 3%
37
Patents All Time

Issued Patents All Time

Showing 1–25 of 37 patents

Patent #TitleCo-InventorsDate
11305144 Abuse potential reduction in abusable substance dosage form Russell L. Morris 2022-04-19
10413768 Abuse potential reduction in abusable substance dosage form Russell L. Morris 2019-09-17
10406394 Abuse potential reduction in abusable substance dosage form Russell L. Morris 2019-09-10
10391346 Abuse potential reduction in abusable substance dosage form Russell L. Morris 2019-08-27
9764130 Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis Walter L. Sembrowich, Russell L. Morris, Robert E. Cohen 2017-09-19
9421356 Transdermal methods and systems for the delivery of corticosteroid compounds Russell L. Morris, Robert E. Cohen, William V. Fowler 2016-08-23
9339856 Transdermal patch disposal system William V. Fowler 2016-05-17
9272137 Transdermal methods and systems for the delivery of anti-migraine compounds Russell L. Morris, Terri Sebree 2016-03-01
8979724 General medication disposal system William V. Fowler, Clayton Anderson 2015-03-17
8790583 Transdermal patch disposal system William V. Fowler 2014-07-29
8535711 Medication disposal system Russell L. Morris 2013-09-17
8475837 Abuse potential reduction in abusable substance dosage form Russell L. Morris 2013-07-02
8470853 Transdermal methods and systems for the delivery of anti-migraine compounds Russell L. Morris, Terri Sebree 2013-06-25
8463373 Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis Walter L. Sembrowich, Russell L. Morris, Robert E. Cohen 2013-06-11
8445010 Abuse potential reduction in abusable substance dosage form Russell L. Morris 2013-05-21
8329212 Abuse potential reduction in abusable substance dosage form Russell L. Morris 2012-12-11
8295924 Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions Russell L. Morris, Robert E. Cohen 2012-10-23
8295923 Sacrificial electrode design and delivery species suitable for prolonged iontophoresis application periods Kathleen A. Eischen, Russell L. Morris 2012-10-23
8239018 Dosage control electrode for iontophoresis device Russell L. Morris 2012-08-07
7973058 Transdermal methods and systems for the delivery of anti-migraine compounds Russell L. Morris, Terri Sebree 2011-07-05
7904146 Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions Russell L. Morris, Robert E. Cohen 2011-03-08
7867511 Abuse potential reduction in abusable substance dosage form Russell L. Morris 2011-01-11
7856263 Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis Walter L. Sembrowich, Russell L. Morris, Robert E. Cohen 2010-12-21
7844327 Dosage control electrode for iontophoresis device Russell L. Morris 2010-11-30
RE41946 Portable immediate response medical analyzer having multiple testing modules David T. Giddings, James D. Kurkowski, Robbi T. Thompson, Kee Van Sin 2010-11-23